BEST UNLIMITED TURBO SHORT CERTIFICATE - ROCHE GS Stock

Certificat

DR57S

DE000SV9JSC2

Market Closed - Euronext Paris 12:30:00 2024-05-20 EDT
2.946 EUR -1.80% Intraday chart for BEST UNLIMITED TURBO SHORT CERTIFICATE - ROCHE GS
Current month-24.60%
1 month-24.36%
Date Price Change
24-05-20 2.946 -1.80%
24-05-17 3 -4.03%
24-05-16 3.126 -10.66%
24-05-15 3.499 -5.79%
24-05-14 3.714 +4.41%

Real-time Euronext Paris

Last update May 20, 2024 at 12:30 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
DR57S
ISINDE000SV9JSC2
Date issued 2023-07-11
Strike 295.6 CHF
Maturity Unlimited
Parity 20 : 1
Emission price 2.51
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.525
Lowest since issue 1.951

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
  1. Stock Market
  2. Certificates
  3. DR57S Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW